These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11899981)

  • 1. New guidelines are a comprehensive resource for managing infection risk among hematopoietic stem cell transplant patients.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Nov; 11(23):1-2, 5. PubMed ID: 11899981
    [No Abstract]   [Full Text] [Related]  

  • 2. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
    Dykewicz CA; ; ;
    Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S32-43. PubMed ID: 8547510
    [No Abstract]   [Full Text] [Related]  

  • 4. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; McNeil MM; Schonberger LB; Navin TR; Hanson DL; Gross PA; Jaffe HW
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S1-11. PubMed ID: 8547495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Infectious complications following hematopoietic stem cell transplantation].
    Akiyama H
    Rinsho Ketsueki; 2008 Aug; 49(8):576-82. PubMed ID: 18800605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Post-transplant infectious diseases].
    Mori T
    Rinsho Ketsueki; 2014 Oct; 55(10):2136-41. PubMed ID: 25297780
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
    Fraser GA; Walker II;
    Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications and risks in hematopoietic stem cell transplant patients.
    Smith LA; Wright-Kanuth MS
    Clin Lab Sci; 2001; 14(2):118-24. PubMed ID: 15625985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for vaccination following hematopoietic stem cell transplantation].
    Azuma E
    Rinsho Ketsueki; 2009 Aug; 50(8):642-51. PubMed ID: 19915379
    [No Abstract]   [Full Text] [Related]  

  • 10. Infections in allogeneic bone marrow transplant recipients.
    Wingard JR
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):80-7. PubMed ID: 8211220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Germs].
    Calbo Torrecillas F
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():165-72. PubMed ID: 2490616
    [No Abstract]   [Full Text] [Related]  

  • 12. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; Wilfert CM; Sperling R; Baker SA; Trapnell CB; Freedberg KA; Cotton D; Powderly WG
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S12-31. PubMed ID: 8547500
    [No Abstract]   [Full Text] [Related]  

  • 13. Case marks evolution in antibiotic drug resistance.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):10, 12. PubMed ID: 12518774
    [No Abstract]   [Full Text] [Related]  

  • 14. New guidelines for fighting multidrug-resistant organisms.
    Walker BW
    Nursing; 2007 May; 37(5):20. PubMed ID: 17468605
    [No Abstract]   [Full Text] [Related]  

  • 15. Update in infectious diseases in liver transplant recipients.
    Huprikar S
    Clin Liver Dis; 2007 May; 11(2):337-54. PubMed ID: 17606211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy.
    Marty FM; Rubin RH
    Transpl Int; 2006 Jan; 19(1):2-11. PubMed ID: 16359371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Battling the 'superbugs'. CDC guidelines conflict with existing standards.
    DoBias M
    Mod Healthc; 2006 Oct; 36(42):10. PubMed ID: 17087155
    [No Abstract]   [Full Text] [Related]  

  • 18. [Infectious complications in the orthoptic liver transplant].
    Repáraz Padrós J
    Rev Med Univ Navarra; 1990; 34(1):41, 43-7, 49-50. PubMed ID: 2096449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Supportive therapy in patients with autologous hemopoietic stem cell transplantation].
    Piatkowska-Jakubas B; Hawrylecka D; Wójcik M; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():108-14. PubMed ID: 10494191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial prophylaxis in hematopoietic stem cell transplantation recipients: 10 years after.
    Trifilio S; Mehta J
    Transpl Infect Dis; 2014 Aug; 16(4):548-55. PubMed ID: 24850416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.